| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |